Osteopontin promotes lesion repair during Staphylococcus aureus skin infections

This study demonstrates that osteopontin (OPN), produced by a specific neutrophil subtype during *Staphylococcus aureus* skin infections, is a critical mediator of tissue repair that accelerates lesion healing and reduces lesion size, suggesting its potential as a therapeutic target for improving infection resolution.

The Gist

Imagine your skin is a fortress wall. When a burglar (in this case, the bacteria Staphylococcus aureus) breaks in, the castle's defense system goes into overdrive. Usually, we think of the defenders (our immune cells) as having one job: kill the burglar and stop the fight.

But this new research reveals a surprising twist: the defenders don't just fight; they also have a special "construction crew" hidden within their ranks that starts rebuilding the wall while the battle is still raging. And the foreman of this construction crew is a protein called Osteopontin (OPN).

Here is the story of how the scientists discovered this, explained in everyday terms:

1. The Battle Scene: A Crowd of Defenders

When the researchers infected mice with S. aureus, they watched what happened over time.

• The Attack: The bacteria set up a fortified camp (an abscess) under the skin, hiding in a slime-like shield (biofilm).
• The Response: The body sent in a massive army of neutrophils (a type of white blood cell). Think of neutrophils as the "shock troops" of the immune system. Their main job is usually to swarm the enemy, eat them, and explode in a burst of chemicals to kill them.
• The Surprise: By day 7, the researchers used a high-tech "microscope camera" (single-cell sequencing) to look at every single cell in the wound. They found that while most neutrophils were busy fighting, a specific subgroup of them had changed their uniforms. They weren't just soldiers anymore; they had become construction managers.

2. The Hidden Foreman: Osteopontin (OPN)

This special group of neutrophils started producing huge amounts of a protein called Osteopontin (OPN).

• The Analogy: Imagine a construction site where the workers are shouting orders to start rebuilding the wall. OPN is the loudspeaker system broadcasting those orders.
• The Discovery: The researchers found that OPN was the most active signal in the wound. It was telling other cells, "Hey, stop fighting for a second and start fixing the hole!"
• The Source: Usually, scientists thought neutrophils only fought. They didn't know these cells could also act as construction managers. The study showed that these cells only get this "construction mode" once they arrive at the infected skin, not while they are just floating in the blood.

3. What Happens Without the Foreman? (The KO Mice)

To prove OPN was the key, the scientists used mice that were genetically engineered to lack OPN (like a construction site with no foreman or loudspeaker).

• The Result: The bacteria were killed just fine in these mice. The "shock troops" did their job of fighting the enemy perfectly.
• The Problem: However, the wound never healed. The holes in the skin stayed open and got much bigger.
• Why? Without OPN, the "construction workers" (fibroblasts and skin cells called keratinocytes) didn't show up in large numbers. The signal to rebuild the wall was missing. The mice had a clean battlefield, but a ruined fortress.

4. The Magic Cure: Giving the Signal Back

The researchers then tried a different experiment. They took normal mice and injected them with extra OPN (the loudspeaker signal) right into the wound.

• The Result: The wounds healed much faster. The scabs fell off sooner, and the skin closed up quickly.
• The Catch: Just like in the knockout mice, the bacteria count didn't change. The extra OPN didn't kill more bacteria; it just made the healing process super efficient.

The Big Takeaway

For a long time, we thought treating skin infections was a two-step process:

1. Kill the bacteria (with antibiotics).
2. Wait for the body to fix the mess.

This paper suggests a new, third step: Help the body fix the mess faster.

The researchers found that our immune system has a built-in "repair switch" (OPN) that gets flipped on by specific neutrophils. If we can turn that switch up (by injecting OPN), we can help wounds heal faster, even if the bacteria are still there.

In simple terms:
Think of a skin infection like a house fire.

• Antibiotics are the fire trucks putting out the flames (killing bacteria).
• OPN is the construction crew that starts rebuilding the roof and walls while the fire trucks are still working.
• This study shows that if you have fire trucks but no construction crew, the house stays ruined. But if you bring in the construction crew (OPN), the house gets fixed much faster, even if the fire isn't 100% out yet.

This discovery opens the door for new medicines that could be used alongside antibiotics to help people with stubborn skin infections heal faster and avoid permanent scarring or recurring infections.

Technical Summary

1. Problem Statement

Skin and soft tissue infections (SSTIs), particularly those caused by Staphylococcus aureus, are a major public health burden in the US. A critical challenge in treating these infections is the delay in tissue repair and re-epithelialization, often exacerbated by S. aureus $\alpha$-hemolysin toxin which causes dermonecrosis. While the mechanisms of bacterial clearance (primarily via neutrophils) are well-studied, the cellular and molecular mechanisms driving tissue repair during an active infection remain poorly understood. Specifically, it is unclear which cell types and signaling molecules facilitate the transition from bacterial containment to tissue regeneration in the context of an infected wound.

2. Methodology

The study employed a multi-modal approach combining in vivo murine models, single-cell transcriptomics, and genetic manipulation:

• In Vivo Model: A dermonecrotic S. aureus skin infection model was established in C57BL/6J mice using intradermal injection of bacteria complexed with Cytodex beads to localize infection. Timepoints were selected at 1, 7, and 14 days post-infection (DPI) to capture inflammation, peak immune response, and repair phases.
• Single-Cell RNA Sequencing (scRNA-seq):
  • 10X Genomics: Used to profile uninfected skin and infected skin at 7 DPI (peak immune response/early repair) to identify cell heterogeneity.
  • Parse Biosciences (Evercode): Used to compare Wild Type (WT) vs. Osteopontin Knockout (OPN KO) mice at 7 and 14 DPI to assess the impact of OPN deficiency on the transcriptomic landscape.
• Genetic Models: Utilized OPN knockout (KO) mice to determine the functional necessity of Osteopontin.
• Therapeutic Intervention: Wild-type mice were treated with intradermal injections of recombinant Osteopontin (rOPN) to test if exogenous OPN could accelerate healing.
• Validation Techniques:
  • Flow Cytometry: Quantified immune cell populations (neutrophils, macrophages, T cells) over time.
  • Immunofluorescence (IF) & Scanning Electron Microscopy (SEM): Visualized bacterial biofilms, abscess formation, and keratinocyte migration (KRT5/KRT6a markers).
  • qPCR: Validated gene expression (specifically Spp1) in neutrophils from bone marrow, blood, and skin.
  • Computational Analysis: Used Seurat for clustering and CellChat for receptor-ligand interaction analysis to map cell-cell communication networks.

3. Key Contributions

• Discovery of Neutrophil Heterogeneity: The study identifies that neutrophils recruited to S. aureus skin infections are not a homogeneous population but consist of distinct subtypes with specialized functions beyond bacterial killing, including antigen presentation and tissue repair.
• Identification of OPN as a Master Regulator: The research pinpoints Osteopontin (encoded by Spp1) as the most significantly upregulated signaling pathway during infection, driven primarily by a specific neutrophil subset.
• Novel Source of OPN: Contrary to previous literature suggesting neutrophils do not express Spp1, this study demonstrates that skin-infiltrating neutrophils are induced to express high levels of OPN in response to local tissue cues, acting as a critical source for tissue repair signaling.
• Therapeutic Proof-of-Concept: The study establishes that exogenous administration of recombinant OPN accelerates wound healing in infected tissue without affecting bacterial load, suggesting a new therapeutic avenue.

4. Key Results

A. Temporal Dynamics of Infection and Repair

• Bacterial load remained stable for 7 days (due to abscess formation and biofilm) before dropping at 14 DPI.
• Neutrophils dominated the lesion site (approx. 90% of CD45+ cells) at 7 DPI.
• Tissue repair (re-epithelialization) began at 7 DPI (indicated by KRT6a expression) and was largely complete by 14 DPI, occurring concurrently with the presence of bacteria.

B. Transcriptomic Landscape and Neutrophil Subsets

• scRNA-seq revealed four distinct neutrophil clusters (Neut1–Neut4) at 7 DPI:
  • Neut1: Enriched for Lrg1 and signaling pathways (Annexin, CD80) associated with inflammation resolution and repair.
  • Neut2: Enriched for antigen presentation machinery (TAP1/2, CD80) and Galectin signaling, potentially aiding IL-17 T-cell responses.
  • Neut3: Classical bacterial killing phenotype (TNF, Complement, Phagosome pathways).
  • Neut4: The primary producers of Spp1 (OPN). This cluster also showed high chemokine/cytokine activity and Toll-like receptor signaling.

C. The Role of Osteopontin (OPN)

• Source: OPN expression was induced specifically in skin-infiltrating neutrophils (Neut4) but was absent in bone marrow or circulating neutrophils, indicating local tissue cues drive its expression.
• Signaling: OPN signals primarily through the CD44 receptor. CellChat analysis identified SPP1 as the top enriched pathway in infected tissue.
• Impact of OPN Deficiency (KO):
  • Cellular Composition: OPN KO mice showed a drastic reduction in fibroblasts (15% in KO vs. 58% in WT at 14 DPI) and keratinocytes.
  • Signaling: Key repair pathways (Desmosome, HSPG, PDGF, NOTCH, SEMA5) were significantly downregulated in KO mice.
  • Phenotype: OPN KO mice developed significantly larger skin lesions compared to WT mice. Crucially, bacterial clearance (CFU counts) was unchanged, proving OPN's role is specific to tissue repair, not bacterial killing.

D. Therapeutic Efficacy of Recombinant OPN

• Treatment of WT mice with intradermal rOPN accelerated lesion resolution.
• rOPN-treated mice shed scabs earlier and had significantly smaller lesion sizes starting at 5 DPI compared to PBS controls.
• Similar to the KO data, rOPN treatment did not alter bacterial burden, confirming its function is purely reparative.

5. Significance

This study fundamentally shifts the understanding of neutrophil function in infection, demonstrating that they are reprogrammed in situ to become active participants in tissue regeneration via OPN secretion.

• Mechanistic Insight: It elucidates the molecular bridge between the immune response and tissue repair, highlighting OPN-CD44 signaling as a critical axis for recruiting fibroblasts and keratinocytes.
• Clinical Translation: The findings suggest that modulating OPN (specifically via recombinant protein administration) could be a potent therapeutic strategy to accelerate healing in chronic or severe S. aureus skin infections.
• Combination Therapy: Since OPN enhances repair without interfering with bacterial clearance, it could be effectively combined with standard antibiotic therapies to improve clinical outcomes, reduce scarring, and prevent infection recurrence.